“The 40-Gene Expression Profile Test Identifies Patients With National Comprehensive Cancer Network High-Risk Cutaneous Squamous Cell Carcinoma at High Risk of Poor Outcomes to Inform Management Decisions”. 2025. SKIN The Journal of Cutaneous Medicine 9 (4): 2426-43. https://doi.org/10.25251/mvr2rn83.